Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

37,801 stories, page 214 of 631

Advanced search

🌍Aug 21Industrydarnytsia.uaTier 3 · Secondary coverage

Препарати для застосування у хірургії

Darnitsa (Ukraine)Original source

🌍Aug 21Industrydarnytsia.uaTier 3 · Secondary coverage

Гастроентерологічні препарати

Darnitsa (Ukraine)Original source

🌍Aug 21Industrydarnytsia.uaTier 3 · Secondary coverage

Дерматологічні препарати

Darnitsa (Ukraine)Original source

🌍Aug 21Industrydarnytsia.uaTier 3 · Secondary coverage

Антибактеріальні препарати та антисептики

Darnitsa (Ukraine)Original source

🌍Aug 21Industrydarnytsia.uaTier 3 · Secondary coverage

Препарати при алергії

Darnitsa (Ukraine)Original source

🌍Aug 21Industrydarnytsia.uaTier 3 · Secondary coverage

Препарати

Darnitsa (Ukraine)Original source

🇺🇰Aug 21Regulatorygov.ukTier 1 · Regulatory source

Air Pollution Awareness Coalition (APAC)

The Air Pollution Awareness Coalition (APAC) is a cross-sector coalition to improve public understan...

UK Department of Health and Social CareOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD

FinancialContentOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

McDonald’s Colaba Licence Suspended by Maharashtra FDA Over Hygiene Violations; Radio Club, Khar Gymkhana

LatestLYOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA suspends licenses of Radio Club, 12 other hotels for violation of hygiene norms

India TV NewsOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

The New Era of Pharma Distribution: Balancing Precision and Scale

Pharmaceutical CommerceOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Guangzhou Baiyunshan Pharmaceutical Holdings Company: Revenue up slightly, net profit down 16.7%, with digital and global expansion ongoing

TradingViewOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Will PBMs' TrumpRx Price Pledge Reach Prescribers?

Pharmaceutical CommerceOriginal source

🌍Aug 21discoverynews.google.comTier 2 · Trade media

Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drug

Fierce BiotechOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Alvotech Signs Licensing Deal With Lotus Pharmaceutical for Proposed Biosimilars

marketscreener.comOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Shanghai Henlius Biotech: Revenue up 27.3% and net profit up 10.3% in 2026 H1, with strong global expansion

TradingViewOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Strategist sees opportunity for health care and biotech stocks

Fox BusinessOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Werewolf Therapeutics Takes Aim At Untapped Pain Market With Ambros Deal

TradingViewOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Israel Englander's HOWL Stock Soars on $500M Deal - Werewolf Therapeutics (NASDAQ:HOWL)

BenzingaOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

China Resources Sanjiu Medical & Pharmaceutical Co: Net profit declined 7.96% despite revenue growth and strong prescription drug sales

TradingViewOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA Suspends Licences Of Radio Club, Khar Gymkhana, And 11 Others Over Hygiene Violations

LatestLYOriginal source

🌍Aug 21discoverynews.google.comTier 2 · Trade media

Are cancer patients getting too much drug?

STATOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

The cost of waiting: what licensing a biotech asset early really saves you

Labiotech.euOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for Biosimilars AVT34 and AVT87

Quiver QuantitativeOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Alvotech Enters Strategic Licensing and Commercialization Agreement with Lotus Pharmaceutical for AVT34 and AVT87

Quiver QuantitativeOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Milestone Pharmaceuticals (MIST) Launches Phase 3 Trial Amidst High Price-to-Sales Valuation

GuruFocusOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Morgan Stanley Issues Positive Forecast for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Price

MarketBeatOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets

Yahoo FinanceOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Henlius Reports 2026 Interim Results: Sustained Profitability Leap, Advancing Global Value Validation, and Accelerating Progress Towards C-MNC

TradingViewOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partner

Investing News NetworkOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Edesa Biotech prices $25 million public offering

The Pharma LetterOriginal source

🇺🇰Aug 21Regulatorygov.ukTier 1 · Regulatory source

JCVI: current advice and recommendations

Current advice and recommendations from the Joint Committee on Vaccination and Immunisation to help...

UK Department of Health and Social CareOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Jordan FDA Mandates Strict Gluten-Free Safety Controls for Celiac Patients

streamlinefeed.co.keOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Commentary: FDA turmoil and political interference threatens drug safety standards

Yakima Herald-RepublicOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Moroccan billionaire Anas Sefrioui expands from property into pharmaceuticals with Servier deal

Business Insider AfricaOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Milestone Pharmaceuticals Enrolls First Patient in Phase 3 ReVeRA-301 Trial of Etripamil for AFib-RVR

Quiver QuantitativeOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

IBBQ vs. PBE: Which Biotech ETF Is the Better Buy?

The Motley FoolOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Taiwan FDA says recalled US berries not imported

Taiwan NewsOriginal source

🇨🇦Aug 21Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

iQ200 Series Analyzers and DxU 840m/850m Iris Analyzers

Beckman Coulter received customer complaints of lamina fluid leaks in iQ200 Series and DxU 840m/850m...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Aug 21Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

ForeSight™ Oximeter Cable

This recall is regarding inaccurate StO2 readings from the HEMFSM10 ForeSight™ Oximeter Cable due to...

Health Canada Recalls and Safety AlertsOriginal source

🇨🇦Aug 21Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Aisys™ CS² and Carestation™

The Aisys™ Carestation™ Anesthesia System, Aisys™ CS² and Aisys™ CS² with Et Control, containing cer...

Health Canada Recalls and Safety AlertsOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Werewolf Therapeutics and Ambros Therapeutics Announce

GlobeNewswireOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

DEA Judge Issues Order On Marijuana Rescheduling Hearing Transcript Corrections

Marijuana MomentOriginal source

🌍Aug 21discoverynews.google.comTier 2 · Trade media

Why Pheast’s CEO has no regrets about transparent approach to R&D despite competitors circling

Fierce BiotechOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Shanghai Henlius Biotech: Revenue up 27.3% to RMB3.59B, profit rises, global expansion and R&D drive growth

TradingViewOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

IBBQ vs. PBE: Which Biotech ETF Is the Better Buy?

The Globe and MailOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Genentech invests $750m in Oregon fill-finish expansion

European Pharmaceutical ReviewOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

CSO is convinced: Moderna's success will boost Evaxion

medwatch.comOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

How Investors May Respond To Ultragenyx Pharmaceutical (RARE) First FDA Accelerated Approval For GENGLYCOS

simplywall.stOriginal source

🌍Aug 21discoverynews.google.comTier 2 · Trade media

Roche commits $750m to double Oregon-based US manufacturing capacity

Pharmaceutical TechnologyOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

Opportunities in the Pharmaceutical Industry in the United States and Mexico

OpportimesOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partner

The Manila TimesOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

NFJ Investment Group LLC Invests $7.76 Million in West Pharmaceutical Services, Inc. $WST

MarketBeatOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

NFJ Investment Group LLC Takes Position in BioMarin Pharmaceutical Inc. $BMRN

MarketBeatOriginal source

🌍Aug 21discoverynews.google.comTier 3 · Aggregated media

40,919 Shares in BioMarin Pharmaceutical Inc. $BMRN Bought by Paralel Advisors LLC

MarketBeatOriginal source

🇪🇺Aug 21Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Teaming to Drive the Future of Genomic Medicine

CORDISOriginal source

🇪🇺Aug 21Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Looking to the past: new evidence on how ancient Babylonian drugs coped with disease

CORDISOriginal source

🇪🇺Aug 21Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Advancing the Technology of PRIME editing to broaden the scope of gene correction therapies

CORDISOriginal source

🇪🇺Aug 21Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Rethinking Drug Response in Leishmania: Identifying the Genomic Determinants of Persistence

CORDISOriginal source

🇪🇺Aug 21Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Excellence Center in Liquid BiopsY in Personalized Medicine (EXCELY)

CORDISOriginal source